Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesNifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis
The Lancet, 07/07/09
Priotto G et al. - The efficacy of NECT is non-inferior to that of eflornithine monotherapy. Since this combination treatment also presents safety advantages, is easier to administer, and potentially protective against the emergence of resistant parasites, it is suitable for first-line use in HAT control programmes.
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/08/09
The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids
European Journal of Immunology, 12/08/09
In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii
The Journal of Antibiotics, 12/08/09
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Subcutaneous Sumatriptan Pharmacokinetics: Delimiting the Monoamine Oxidase Inhibitor Effect
Headache: The Journal of Head and Face Pain, 12/08/09
Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
American Journal of Health-System Pharmacy, 12/08/09
Potential interactions between cilostazol and probucol: A two-part, single-dose, open-label study in healthy Korean male volunteers
Clinical Therapeutics, 12/07/09
Sponsor
Article Search
Sponsor